TrialParkinsonism & related disorders2022
A pilot to assess target engagement of terazosin in Parkinson's disease.
Jordan L Schultz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
33 papers cite it
this paperpooled ittrialcites it